Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

GM-CSF in the lung protects against lethal influenza infection.

Huang FF, Barnes PF, Feng Y, Donis R, Chroneos ZC, Idell S, Allen T, Perez DR, Whitsett JA, Dunussi-Joannopoulos K, Shams H.

Am J Respir Crit Care Med. 2011 Jul 15;184(2):259-68. doi: 10.1164/rccm.201012-2036OC. Epub 2011 Apr 7.

PMID:
21474645
2.

Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair.

Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):521-32. doi: 10.1164/rccm.200812-1837OC. Epub 2009 Jul 9.

PMID:
19590023
3.

Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung.

Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ, Auerbach W, Eynon EE, Stevens S, Manz MG, Flavell RA.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2390-5. doi: 10.1073/pnas.1019682108. Epub 2011 Jan 24.

4.

Delivery of GM-CSF to Protect against Influenza Pneumonia.

Subramaniam R, Hillberry Z, Chen H, Feng Y, Fletcher K, Neuenschwander P, Shams H.

PLoS One. 2015 Apr 29;10(4):e0124593. doi: 10.1371/journal.pone.0124593. eCollection 2015.

5.

Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury.

Paine R 3rd, Wilcoxen SE, Morris SB, Sartori C, Baleeiro CE, Matthay MA, Christensen PJ.

Am J Pathol. 2003 Dec;163(6):2397-406.

6.

GM-CSF modulates pulmonary resistance to influenza A infection.

Sever-Chroneos Z, Murthy A, Davis J, Florence JM, Kurdowska A, Krupa A, Tichelaar JW, White MR, Hartshorn KL, Kobzik L, Whitsett JA, Chroneos ZC.

Antiviral Res. 2011 Nov;92(2):319-28. doi: 10.1016/j.antiviral.2011.08.022. Epub 2011 Sep 8.

8.

Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.

Paine R 3rd, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, Reed JA, Ross G, Whitsett JA, Beck JM.

J Immunol. 2000 Mar 1;164(5):2602-9.

9.

Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.

Ballinger MN, Paine R 3rd, Serezani CH, Aronoff DM, Choi ES, Standiford TJ, Toews GB, Moore BB.

Am J Respir Cell Mol Biol. 2006 Jun;34(6):766-74. Epub 2006 Feb 10.

10.

FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

Abdul-Careem MF, Firoz Mian M, Gillgrass AE, Chenoweth MJ, Barra NG, Chan T, Al-Garawi AA, Chew MV, Yue G, van Roojen N, Xing Z, Ashkar AA.

Antiviral Res. 2011 Nov;92(2):346-55. doi: 10.1016/j.antiviral.2011.09.004. Epub 2011 Sep 14.

PMID:
21945041
11.

GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection.

LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA.

J Clin Invest. 1999 Feb;103(4):563-9.

12.

Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.

Ballinger MN, Hubbard LL, McMillan TR, Toews GB, Peters-Golden M, Paine R 3rd, Moore BB.

Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L114-22. doi: 10.1152/ajplung.00309.2007. Epub 2008 May 2.

13.

GM-CSF and influenza: will saving mice help humans?

Waterer G.

Am J Respir Crit Care Med. 2011 Jul 15;184(2):157-8. doi: 10.1164/rccm.201105-0833ED. No abstract available.

PMID:
21765031
14.

Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice.

Paine R 3rd, Morris SB, Jin H, Wilcoxen SE, Phare SM, Moore BB, Coffey MJ, Toews GB.

Am J Physiol Lung Cell Mol Physiol. 2001 Nov;281(5):L1210-8.

16.

Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages.

Wu H, Suzuki T, Carey B, Trapnell BC, McCormack FX.

J Biol Chem. 2011 Apr 29;286(17):14932-40. doi: 10.1074/jbc.M110.182170. Epub 2011 Feb 22.

17.

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, Matsushita I, Seymour JF, Oh-Eda M, Ishige I, Eishi Y, Kitamura T, Yamada Y, Hanaoka K, Keicho N.

Blood. 2004 Feb 1;103(3):1089-98. Epub 2003 Sep 25.

18.

Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.

Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ.

J Leukoc Biol. 2006 Jan;79(1):133-9. Epub 2005 Nov 7.

19.

GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice.

Hawgood S, Akiyama J, Brown C, Allen L, Li G, Poulain FR.

Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1148-56.

20.

GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress.

Baleeiro CE, Christensen PJ, Morris SB, Mendez MP, Wilcoxen SE, Paine R 3rd.

Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1246-55. Epub 2006 Aug 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk